Practical Geriatrics ›› 2022, Vol. 36 ›› Issue (12): 1259-1263.doi: 10.3969/j.issn.1003-9198.2022.12.018

Previous Articles     Next Articles

Predictive value of preoperative hemoglobin, albumin, lymphocyte and platelet(HALP) score for prognosis of elderly patients with non-small cell lung cancer undergoing surgery

YUAN Meng-yi, WANG Pei-shan, MENG Rui-xia, YANG Jian-jun, ZHOU Cheng-mao, JIAO Zhong-yu   

  1. YUAN Meng-yi, JIAO Zhong-yu. The Fourth Clinical College of Xinxiang Medical College, Xinxiang 453000, China;
    WANG Pei-shan, MENG Rui-xia.Department of Anesthesiology, Xinxiang Central Hospital, Xinxiang 453000, China;
    YANG Jian-jun, ZHOU Cheng-mao. Department of Anesthesiology,the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China
  • Received:2022-01-04 Online:2022-12-20 Published:2022-11-30

Abstract: Objective To investigate the predictive value of preoperative hemoglobin, albumin, lymphocyte and platelet (HALP) score for the prognosis of the elderly patients with non-small cell lung cancer (NSCLC) undergoing surgery. Methods The clinical data of 270 elderly patients with NSCLC undergoing surgery in Xinxiang Central Hospital from January 2015 to December 2019 were collected, and the predictive value of HALP score for the prognosis was analyzed. Results Univariate Cox regression analysis showed that preoperative HALP score, ΔHALP score, tumor TNM stage, tumor differentiation, smoking history, tumor location, serum albumin level, hemoglobin level and postoperative hospital stay were associated with postoperative overall survival (OS) and progression-free survival (PFS) (all P<0.05). Multivariate Cox regression analysis showed that preoperative HALP score, tumor TNM stage and tumor differentiation were the independent risk factors for OS and PFS, and preoperative serum albumin level was an independent risk factor for OS (all P<0.05). Conclusions HALP score can be used as a predictor for postoperative survival in the elderly patients with NSCLC after surgery, which could assist clinical targeted intervention to improve prognosis.

Key words: aged, non-small cell lung cancer, nutrition, inflammation, immunity, HALP score

CLC Number: